WBC
MRVI icon

Westpac Banking Corp’s Maravai LifeSciences MRVI Stock Holding History

Westpac Banking Corp’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-103,828
Closed -$2.65M – 777
2022
Q3 		$2.65M Sell
103,828
-87,400
-46% -$2.19M 0.04% 454
2022
Q2 		$5.43M Buy
191,228
+53,000
+38% +$1.68M 0.07% 353
2022
Q1 		$4.88M Sell
138,228
-6,649
-5% -$223K 0.06% 393
2021
Q4 		$6.07M Buy
+144,877
New +$5.87M 0.06% 365

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Westpac Banking Corp's MRVI Position: Q4 2022 in Review

Westpac Banking Corp sold out of Maravai LifeSciences (MRVI) in Q4 2022, closing a stake of 103,828 shares — an estimated $2.65M sold.

Westpac Banking Corp first reported a position in MRVI in Q4 2021 and held it in 4 quarters. The position peaked at $6.07M in Q4 2021. 212 funds tracked by Wall St. Rank hold MRVI as of Q4 2022.

  • Westpac Banking Corp reported no remaining Maravai LifeSciences position as of Q4 2022 after selling out during the quarter.
  • Westpac Banking Corp sold 103,828 Maravai LifeSciences shares in Q4 2022, an estimated $2.65M.
  • Westpac Banking Corp first reported a position in Maravai LifeSciences in Q4 2021 and held it in 4 quarters.
  • Westpac Banking Corp's Maravai LifeSciences position peaked at $6.07M in Q4 2021.
  • 212 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2022.

Based on Westpac Banking Corp's 13F filing for Q4 2022, filed 6 Feb 2023.